VRSK CEO Shavel Lee Sells 2,200 Shares Under 10b5-1 Plan

Verisk Analytics insider sales by CEO/Director Shavel Lee reduced his holdings under a pre-established 10b5-1 plan.

Rhea-AI Filing Summary

Verisk Analytics insider sales by CEO/Director Shavel Lee reduced his holdings under a pre-established 10b5-1 plan. The Form 4 reports two separate open-market dispositions: 1,100 shares sold on 08/15/2025 at $268.00 and 1,100 shares sold on 08/18/2025 at $268.01. The filings show Mr. Lee owned 80,007 shares before the first reported sale and 78,907 shares after the second sale. The Form indicates the sales were made pursuant to a 10b5-1 trading plan established on November 25, 2024.

Insights

Financial Analyst

TL;DR: CEO executed routine 10b5-1 sales totaling 2,200 shares at roughly $268 each, leaving ~78.9k shares outstanding for his beneficial ownership.

The trades disclosed are orderly dispositions under a pre-existing 10b5-1 plan, which typically indicates scheduled selling rather than opportunistic trading. The amounts—2,200 shares—are small relative to total holdings reported and do not, by themselves, signal a change in company fundamentals. For investors, this is a disclosure of liquidity activity by management, not an operational update. No derivative transactions or other compensatory transfers are reported.

Corporate Governance Expert

TL;DR: Sales were executed under a 10b5-1 plan, consistent with governance best practices for insider liquidity.

Reporting the 10b5-1 plan and using an attorney-in-fact signature shows compliance with Section 16 reporting requirements. The explanation explicitly ties the sales to the November 25, 2024 plan, which supports an affirmative defense under Rule 10b5-1(c). The filing contains no amendments or indications of non-routine governance events. From a disclosure and compliance perspective, the filing appears complete and routine.

Insider Trade Summary

Net Seller: 2,200 shares

Net Sell 2 txns

Insider Shavel Lee

Role Chief Executive Officer

Sold 2,200 shs ($590K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,100	$268.01	$295K
Sale	Common Stock	1,100	$268.00	$295K

Holdings After Transaction: Common Stock — 78,907 shares (Direct)

Footnotes (1)

1. F1. These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Shavel on November 25, 2024.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Verisk Analytics (VRSK) report on this Form 4?

The filing reports CEO/Director Shavel Lee sold 1,100 shares on 08/15/2025 at $268.00 and 1,100 shares on 08/18/2025 at $268.01, totaling 2,200 shares sold.

Were the sales by Shavel Lee part of a 10b5-1 trading plan?

Yes. The Form 4 states the shares were sold pursuant to a 10b5-1 plan entered into on November 25, 2024.

How many shares did Shavel Lee own after the reported transactions?

Following the reported sales, the Form 4 shows Shavel Lee beneficially owned 78,907 shares.

Did the Form 4 report any derivative transactions or option exercises?

No. Table II for derivative securities contains no reported transactions; only non-derivative common stock sales are disclosed.

Who signed the Form 4 and when was it filed?

The form is signed by Kathy Card Beckles, Attorney-in-fact on 08/18/2025 as the reporting signature.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2025 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shavel Lee

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		1,100(1)	D	$268	80,007	D
Common Stock	08/18/2025		S		1,100(1)	D	$268.01	78,907	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Shavel on November 25, 2024.

	/s/ Kathy Card Beckles, Attorney-in-fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.